Abstract: . . .  future IHD events         Thrombosis Prevention Trial   -1983-92, Great Britain -low-dose antithrombotic treatment in preventing angina and major CHD -Prevention of CHD- results published in 1998       . . .
. . .  practices in Great Britain Demographics not reported, but most likely Caucasian High risk patients     Is the treatment feasible?   Requires monitoring of INR at least once every 6 months Study was conducted in a controlled environment . . .
. . .  of angina lowered by warfarin? More evidence needed 2. Low dose warfarin prevents CHD in high risk patients- must weigh risks and benefits. 3. ASA increases incidence of angina significantly      . . .
. . .  7   Hemorrhagic stroke   4   8   9   12   Other major bleed (GI + others)   P (n=1272)   A (n=1268)   W (n=1268)   WA (n=1277)     . . .
. . .  evidence needed 2. Low dose warfarin prevents CHD in high risk patients- must weigh risks and benefits. 3. ASA increases incidence of angina significantly      . . .
. . .  needed 2. Low dose warfarin prevents CHD in high risk patients- must weigh risks and benefits. 3. ASA increases incidence of angina significantly      . . .
--1555,6,130,1785,7774